In the Orphacol case, which concerns a medicinal product the European Commission refuses to authorise, the EU General Court rejected, in a 4 July judgement (Case T-12/12), the case brought by the laboratory but ordered the European Commission to pay...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
Commission to introduce mandatory accessibility features - 04/12/2012
Dalli affair: MEPs call for explanation - 04/12/2012
Commission to introduce mandatory accessibility features - 
